Henry A. Nasrallah, MD | Psychiatrist.com

Psychosis, Inflammatory Biomarkers, and Subtypes of Childhood Trauma

Commentary

Psychosis, Inflammatory Biomarkers, and Subtypes of Childhood Trauma

May 22, 2024

Dr Nasrallah discusses a recent study by Cuñat et al of the relationship between childhood trauma and inflammation, and why this work is unique and important.

Henry A. Nasrallah

Original Research

Metabolic Effects of Aripiprazole Lauroxil

November 23, 2016

Aripiprazole lauroxil, a long-acting injectable antipsychotic, demonstrated safety and efficacy in treating schizophrenia symptoms in a recent RCT. But how does it stack up against other antipsychotics in terms...

Henry A. Nasrallah, John W. Newcomer, Robert Risinger, et al

Educational Activity

Consequences of Misdiagnosis: Inaccurate Treatment and Poor Patient Outcomes in Bipolar Disorder

October 21, 2015

Henry A. Nasrallah

Book Review

Treatment-Refractory Schizophrenia: A Clinical Conundrum

September 23, 2015

Henry A. Nasrallah

Original Research

A Randomized, Double-Blind, Placebo-Controlled Trial of Aripiprazole Lauroxil in Acute Exacerbation of Schizophrenia

August 26, 2015

Herbert Y. Meltzer, Robert Risinger, Henry A. Nasrallah, et al

Educational Activity

Setting the Stage for Success or Failure: Making an Accurate Diagnosis of Bipolar Depression

June 24, 2015

Henry A. Nasrallah

Book Review

Management of Treatment-Resistant Major Psychiatric Disorders

October 15, 2013

Henry A. Nasrallah

Book Review

Antipsychotics and Mood Stabilizers: Stahl's Essential Psychopharmacology, 3rd ed

June 18, 2009

Henry A. Nasrallah

Article

Proceedings and Data From The Schizophrenia Summit: A Critical Appraisal to Improve the Management of Schizophrenia

March 4, 2009

Henry A. Nasrallah, Matcheri S. Keshavan, Francine M. Benes David, et al

Article

Introduction. Evaluating the Evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and Beyond

January 15, 2007

Henry A. Nasrallah

Article

The Roles of Efficacy, Safety, and Tolerability in Antipsychotic Effectiveness: Practical Implications of the CATIE Schizophrenia Trial

January 15, 2007

Henry A. Nasrallah

Article

An Overview of Common Medical Comorbidities in Patients With Schizophrenia

August 15, 2005

Henry A. Nasrallah

1 2 »